Albert Friedberg - 28 Mar 2024 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director, 10%+ Owner
Signature
/s/ Maurice Zauderer, Attorney-in-Fact for Albert Friedberg
Issuer symbol
VCNX
Transactions as of
28 Mar 2024
Net transactions value
+$1,599,998
Form type
4
Filing time
01 Apr 2024, 20:53:49 UTC
Previous filing
09 Feb 2024
Next filing
22 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCNX Common Stock Award $799,999 +102,960 +23% $7.77 560,315 28 Mar 2024 By FCMI Parent Co. F3
holding VCNX Common Stock 2,094 28 Mar 2024 Direct
holding VCNX Common Stock 180 28 Mar 2024 By Pan Atlantic Holdings Ltd. F1
holding VCNX Common Stock 16,724 28 Mar 2024 By Friedberg Global-Macro Hedge Fund Ltd. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Warrant (Right to Buy) Award $799,999 +102,960 $7.77 102,960 28 Mar 2024 Common Stock 102,960 $7.64 By FCMI Parent Co. F3
holding VCNX Warrant (Right to Buy) 118,226 28 Mar 2024 Common Stock 118,226 $14.00 By FCMI Parent Co. F3
holding VCNX Warrant (Right to Buy) 214,285 28 Mar 2024 Common Stock 214,285 $14.00 By FCMI Parent Co. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Friedberg is the majority owner of Pan Atlantic Holdings Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2 Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3 Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Remarks:

On February 19, 2024, Vaccinex, Inc. effected a 1-for-14 reverse stock split (the "Reverse Stock Split"). The figures in this Form 4 reflect the Reverse Stock Split.